 |
PDBsum entry 2w5y
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Binary complex of the mixed lineage leukaemia (mll1) set domain with the cofactor product s-adenosylhomocysteine.
|
|
Structure:
|
 |
Histone-lysine n-methyltransferase hrx. Chain: a. Fragment: methyltransferase domain, residues 3785-3969. Synonym: zinc finger protein hrx, all-1, trithorax-like protein, lysine n-methyltransferase 2a, cxxc-type zinc finger protein 7, mll- 1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008. Expression_system_variant: rosetta 2.
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.191
|
R-free:
|
0.264
|
|
|
Authors:
|
 |
S.M.Southall,P.S.Wong,Z.Odho,S.M.Roe,J.R.Wilson
|
Key ref:
|
 |
S.M.Southall
et al.
(2009).
Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.
Mol Cell,
33,
181-191.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
15-Dec-08
|
Release date:
|
10-Feb-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q03164
(KMT2A_HUMAN) -
Histone-lysine N-methyltransferase 2A from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
3969 a.a.
170 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.1.1.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.1.1.364
- [histone H3]-lysine(4) N-methyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-lysyl4-[histone H3] + S-adenosyl-L-methionine = N6-methyl-L- lysyl4-[histone H3] + S-adenosyl-L-homocysteine + H+
|
 |
 |
 |
 |
 |
L-lysyl(4)-[histone H3]
|
+
|
S-adenosyl-L-methionine
|
=
|
N(6)-methyl-L- lysyl(4)-[histone H3]
|
+
|
S-adenosyl-L-homocysteine
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
33:181-191
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.
|
|
S.M.Southall,
P.S.Wong,
Z.Odho,
S.M.Roe,
J.R.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The mixed-lineage leukemia protein MLL1 is a transcriptional regulator with an
essential role in early development and hematopoiesis. The biological function
of MLL1 is mediated by the histone H3K4 methyltransferase activity of the
carboxyl-terminal SET domain. We have determined the crystal structure of the
MLL1 SET domain in complex with cofactor product AdoHcy and a histone H3
peptide. This structure indicates that, in order to form a well-ordered active
site, a highly variable but essential component of the SET domain must be
repositioned. To test this idea, we compared the effect of the addition of MLL
complex members on methyltransferase activity and show that both RbBP5 and Ash2L
but not Wdr5 stimulate activity. Additionally, we have determined the effect of
posttranslational modifications on histone H3 residues downstream and upstream
from the target lysine and provide a structural explanation for why H3T3
phosphorylation and H3K9 acetylation regulate activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Overall Structure of the MLL1 SET Domain (A)
Schematic representation of the full-length MLL1 protein and the
construct containing the SET domain used in structural studies
(residues 3785–3969), indicating the subdomains referred to in
the text. The N-flanking region is in pale blue, the SET-N in
pale green, the SET-I in blue, the SET-C in bright green, and
the postSET domain in orange. (B) Sequence of the MLL1 SET
domain aligned with MLL1, Dim-5, Suv39h2, Set7/9, and PRSet7.
The SET domain region secondary structure elements derived from
the structure are indicated above the sequence. Identical
residues are highlighted in red, conserved cysteines involved in
Zn binding in orange, and active site residues in blue. (C)
Two views of a cartoon representation of the MLL1 SET domain
structure with a stick representation of the cofactor product
AdoHcy (gray) and histone peptide substrate (purple).
|
 |
Figure 3.
Figure 3. Ordering of the MLL1 Active Site (A) Overlay
of the SET-I region and C-flanking region of MLL1 (gray), and
Dim-5 (yellow, PDB; 1PEG). Structures are superposed on their
cofactors and overlap on their C-flanking domains. (B)
Superposition of active site residues in the SET domains of MLL1
and Dim-5 showing the displacement of the channel tetrapeptide
in MLL1. (C) Reorientation of SET-I; surface representation
of the MLL1 ternary complex on the left showing open
configuration of the active site. On the right, the MLL1 Set-I
domain (green) has been modeled to align with the position
observed in Dim5. (D) Schematic representation of the MLL1
complex. (E) Methyltransferase activity of MLL1 in the
presence of Ash2L-Dpy30 heterodimer Wdr5-RbBP5 heterodimer,
Wdr5, RbBP5, and Ash2L-DPY30 + Wdr5-RbBP5. Activity is
represented as the mean of triplicate measurements, with error
bars indicating one standard deviation.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2009,
33,
181-191)
copyright 2009.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
V.Migliori,
J.Müller,
S.Phalke,
D.Low,
M.Bezzi,
W.C.Mok,
S.K.Sahu,
J.Gunaratne,
P.Capasso,
C.Bassi,
V.Cecatiello,
A.De Marco,
W.Blackstock,
V.Kuznetsov,
B.Amati,
M.Mapelli,
and
E.Guccione
(2012).
Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance.
|
| |
Nat Struct Mol Biol,
19,
136-144.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.K.Upadhyay,
and
X.Cheng
(2011).
Dynamics of histone lysine methylation: structures of methyl writers and erasers.
|
| |
Prog Drug Res,
67,
107-124.
|
 |
|
|
|
|
 |
S.Krishnan,
S.Horowitz,
and
R.C.Trievel
(2011).
Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
|
| |
Chembiochem,
12,
254-263.
|
 |
|
|
|
|
 |
S.S.Oliver,
and
J.M.Denu
(2011).
Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a "histone language".
|
| |
Chembiochem,
12,
299-307.
|
 |
|
|
|
|
 |
V.Avdic,
P.Zhang,
S.Lanouette,
A.Groulx,
V.Tremblay,
J.Brunzelle,
and
J.F.Couture
(2011).
Structural and biochemical insights into MLL1 core complex assembly.
|
| |
Structure,
19,
101-108.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Tuukkanen,
B.Huang,
A.Henschel,
F.Stewart,
and
M.Schroeder
(2010).
Structural modeling of histone methyltransferase complex Set1C from Saccharomyces cerevisiae using constraint-based docking.
|
| |
Proteomics,
10,
4186-4195.
|
 |
|
|
|
|
 |
F.Cao,
Y.Chen,
T.Cierpicki,
Y.Liu,
V.Basrur,
M.Lei,
and
Y.Dou
(2010).
An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.
|
| |
PLoS One,
5,
e14102.
|
 |
|
|
|
|
 |
H.Richly,
M.Lange,
E.Simboeck,
and
L.Di Croce
(2010).
Setting and resetting of epigenetic marks in malignant transformation and development.
|
| |
Bioessays,
32,
669-679.
|
 |
|
|
|
|
 |
H.Wei,
and
M.M.Zhou
(2010).
Dimerization of a viral SET protein endows its function.
|
| |
Proc Natl Acad Sci U S A,
107,
18433-18438.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Wu,
J.Min,
V.V.Lunin,
T.Antoshenko,
L.Dombrovski,
H.Zeng,
A.Allali-Hassani,
V.Campagna-Slater,
M.Vedadi,
C.H.Arrowsmith,
A.N.Plotnikov,
and
M.Schapira
(2010).
Structural biology of human H3K9 methyltransferases.
|
| |
PLoS One,
5,
e8570.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Higgins
(2010).
Haspin: a newly discovered regulator of mitotic chromosome behavior.
|
| |
Chromosoma,
119,
137-147.
|
 |
|
|
|
|
 |
K.L.Yap,
and
M.M.Zhou
(2010).
Keeping it in the family: diverse histone recognition by conserved structural folds.
|
| |
Crit Rev Biochem Mol Biol,
45,
488-505.
|
 |
|
|
|
|
 |
M.D.Taylor,
S.Sadhukhan,
P.Kottangada,
A.Ramgopal,
K.Sarkar,
S.D'Silva,
A.Selvakumar,
F.Candotti,
and
Y.M.Vyas
(2010).
Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
|
| |
Sci Transl Med,
2,
37ra44.
|
 |
|
|
|
|
 |
M.S.Cosgrove,
and
A.Patel
(2010).
Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.
|
| |
FEBS J,
277,
1832-1842.
|
 |
|
|
|
|
 |
P.F.South,
I.M.Fingerman,
D.P.Mersman,
H.N.Du,
and
S.D.Briggs
(2010).
A conserved interaction between the SDI domain of Bre2 and the Dpy-30 domain of Sdc1 is required for histone methylation and gene expression.
|
| |
J Biol Chem,
285,
595-607.
|
 |
|
|
|
|
 |
R.D.Morin,
N.A.Johnson,
T.M.Severson,
A.J.Mungall,
J.An,
R.Goya,
J.E.Paul,
M.Boyle,
B.W.Woolcock,
F.Kuchenbauer,
D.Yap,
R.K.Humphries,
O.L.Griffith,
S.Shah,
H.Zhu,
M.Kimbara,
P.Shashkin,
J.F.Charlot,
M.Tcherpakov,
R.Corbett,
A.Tam,
R.Varhol,
D.Smailus,
M.Moksa,
Y.Zhao,
A.Delaney,
H.Qian,
I.Birol,
J.Schein,
R.Moore,
R.Holt,
D.E.Horsman,
J.M.Connors,
S.Jones,
S.Aparicio,
M.Hirst,
R.D.Gascoyne,
and
M.A.Marra
(2010).
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.
|
| |
Nat Genet,
42,
181-185.
|
 |
|
|
|
|
 |
S.Katada,
and
P.Sassone-Corsi
(2010).
The histone methyltransferase MLL1 permits the oscillation of circadian gene expression.
|
| |
Nat Struct Mol Biol,
17,
1414-1421.
|
 |
|
|
|
|
 |
A.Patel,
V.Dharmarajan,
V.E.Vought,
and
M.S.Cosgrove
(2009).
On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
|
| |
J Biol Chem,
284,
24242-24256.
|
 |
|
|
|
|
 |
R.C.Trievel,
and
A.Shilatifard
(2009).
WDR5, a complexed protein.
|
| |
Nat Struct Mol Biol,
16,
678-680.
|
 |
|
|
|
|
 |
R.K.Slany
(2009).
The molecular biology of mixed lineage leukemia.
|
| |
Haematologica,
94,
984-993.
|
 |
|
|
|
|
 |
R.Margueron,
N.Justin,
K.Ohno,
M.L.Sharpe,
J.Son,
W.J.Drury,
P.Voigt,
S.R.Martin,
W.R.Taylor,
V.De Marco,
V.Pirrotta,
D.Reinberg,
and
S.J.Gamblin
(2009).
Role of the polycomb protein EED in the propagation of repressive histone marks.
|
| |
Nature,
461,
762-767.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Petrossian,
and
S.Clarke
(2009).
Bioinformatic Identification of Novel Methyltransferases.
|
| |
Epigenomics,
1,
163-175.
|
 |
|
|
|
|
 |
Y.H.Takahashi,
J.S.Lee,
S.K.Swanson,
A.Saraf,
L.Florens,
M.P.Washburn,
R.C.Trievel,
and
A.Shilatifard
(2009).
Regulation of H3K4 trimethylation via Cps40 (Spp1) of COMPASS is monoubiquitination independent: implication for a Phe/Tyr switch by the catalytic domain of Set1.
|
| |
Mol Cell Biol,
29,
3478-3486.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |